Crossmark

Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1

Crossref DOI link: https://doi.org/10.1039/C8OB00706C

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Tanaka, Keisuke

Kasahara, Yuuya https://orcid.org/0000-0002-1102-9795
Miyamoto, Yoichi

Takumi, Okuda

Kasai, Tatsuro

Onodera, Kentaro

Kuwahara, Masayasu https://orcid.org/0000-0002-0810-4627
Oka, Masahiro

Yoneda, Yoshihiro

Obika, Satoshi https://orcid.org/0000-0002-6842-6812
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (Platform Project for Supporting Drug Discovery and Life Science Research (No. JP17am0301004))

Japan Society for the Promotion of Science (Aid for Scientific Research (C)/No. 15K07068, Aid for Scientific Research (B)/No. 16H04789)
License Information

Accepted Manuscript valid from 2019-05-31
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

ASSOCIATED ARTICLES

CrossRef DOI Link to Correction:: https://doi.org/10.1039/C8OB90140F

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Yuuya Kasahara (ORCID)

: Masayasu Kuwahara (ORCID)

: Satoshi Obika (ORCID)

: Satoshi Obika (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 23 March 2018; Accepted 24 May 2018; Advance Article published 31 May 2018; Version of Record published 20 June 2018